- Home
- OLP vs CRMD Comparison
OLP vs CRMD Comparison
Compare OLP & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLP
- CRMD
- Stock Information
- Founded
- OLP 1982
- CRMD 2006
- Country
- OLP United States
- CRMD United States
- Employees
- OLP N/A
- CRMD N/A
- Industry
- OLP Real Estate Investment Trusts
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- OLP Real Estate
- CRMD Health Care
- Exchange
- OLP Nasdaq
- CRMD Nasdaq
- Market Cap
- OLP 622.6M
- CRMD 576.4M
- IPO Year
- OLP N/A
- CRMD 2010
- Fundamental
- Price
- OLP $25.94
- CRMD $12.71
- Analyst Decision
- OLP Strong Buy
- CRMD Strong Buy
- Analyst Count
- OLP 1
- CRMD 6
- Target Price
- OLP $28.00
- CRMD $15.67
- AVG Volume (30 Days)
- OLP 69.0K
- CRMD 1.2M
- Earning Date
- OLP 03-04-2025
- CRMD 10-30-2024
- Dividend Yield
- OLP 7.00%
- CRMD N/A
- EPS Growth
- OLP 51.11
- CRMD N/A
- EPS
- OLP 1.63
- CRMD N/A
- Revenue
- OLP $89,142,000.00
- CRMD $12,262,234.00
- Revenue This Year
- OLP N/A
- CRMD N/A
- Revenue Next Year
- OLP $4.71
- CRMD $300.00
- P/E Ratio
- OLP $15.79
- CRMD N/A
- Revenue Growth
- OLP N/A
- CRMD 41184.20
- 52 Week Low
- OLP $19.25
- CRMD $2.89
- 52 Week High
- OLP $30.45
- CRMD $13.85
- Technical
- Relative Strength Index (RSI)
- OLP 36.21
- CRMD 71.01
- Support Level
- OLP $24.82
- CRMD $7.91
- Resistance Level
- OLP $26.09
- CRMD $11.50
- Average True Range (ATR)
- OLP 0.57
- CRMD 0.57
- MACD
- OLP -0.08
- CRMD 0.43
- Stochastic Oscillator
- OLP 34.40
- CRMD 93.02
About OLP One Liberty Properties Inc.
One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio of industrial, retail, restaurant, health and fitness, and theater properties. OLP owns hundred and ten properties, including three properties owned by consolidated joint ventures and two properties owned by unconsolidated joint ventures. The hundred and ten properties are located in thirty one states. The group generates the majority of its revenue in the form of rental income.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.